A Path Analysis Modeling of the Interaction of AXII and/or AXIIR with the Changes in Cytokines and Myeloma Bone Disease
G
G. David Roodman, MD, PhD
Primary Investigator
Overview
The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.
Description
The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Multiple Myeloma
-
Age: Between 18 Years - 90 Years
-
Gender: All
Inclusion Criteria
Diagnosed with multiple myeloma
Diagnosed with multiple myeloma
Exclusion Criteria
Currently pregnant
Are allergic to xylocaine
Currently enrolled in another research study
Participants may be paid for their participation.
Updated on
25 Apr 2024.
Study ID: 1204008459 (IUCRO-0373)